Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

KORKMAZ T., Seber S., KEFELI U., SARI E., Canhoroz M., OVEN B., YILDIRIM E., YASAR N., AYDIN D., BALVAN O., et al.

doi:10.1007/s12094-012-0960-6

Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

KORKMAZ T., Seber S., KEFELI U., SARI E., Canhoroz M., OVEN B., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.15, ss.535-540, 2013

Cilt numarası: 15 Konu: 7
Basım Tarihi: 2013
Doi Numarası: 10.1007/s12094-012-0960-6
Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
Sayfa Sayısı: ss.535-540

Özet

Small cell lung cancer (SCLC) has a high relapse rate despite being very chemosensitive. The efficacy of second-line treatment is dismal. Our aim was to evaluate the outcome of second-line treatment.